Cannabix Technologies (FRA:8CT) 3-Year RORE % : 25.00% (As of Jan. 2026)


FRA:8CT Cannabix Technologies Inc FRA:8CT
32 GF Score
Price €0.36
! 2 Warning Signs
View Full Analysis

What is Cannabix Technologies 3-Year RORE %?

Cannabix Technologies FRA:8CT +7.14% 32 3-Year RORE % is 25.00 as of Jan. 2026. GuruFocus rates FRA:8CT with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 781 Medical Devices & Instruments companies, Cannabix Technologies ranks better than 78.62% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Cannabix Technologies's 3-Year RORE % for the quarter that ended in Jan. 2026 was 25.00%.

The industry rank for Cannabix Technologies's 3-Year RORE % or its related term are showing as below:

FRA:8CT's 3-Year RORE % is ranked better than
78.62% of 781 companies
in the Medical Devices & Instruments industry
Industry Median: -4.19 vs FRA:8CT: 25.00

Cannabix Technologies  (FRA:8CT) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Cannabix Technologies 3-Year RORE % Related Terms


Cannabix Technologies 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Cannabix Technologies's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabix Technologies 3-Year RORE % Chart

Cannabix Technologies Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.22 -21.58 -40.38 -11.67 3.51

Cannabix Technologies Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.00 3.51 13.64 17.65 25.00

FRA:8CT vs ABT, SYK, MDT: 3-Year RORE % Comparison

For the Medical Devices subindustry, Cannabix Technologies's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabix Technologies 3-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cannabix Technologies's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Cannabix Technologies's 3-Year RORE % falls into.


FRA:8CT
32GF Score
Cannabix Technologies Inc FRA:8CT
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cannabix Technologies 3-Year RORE % Calculation

Cannabix Technologies's 3-Year RORE % for the quarter that ended in Jan. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.033--0.017 )/( -0.064-0 )
=-0.016/-0.064
=25.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jan. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 25.00 mean?
Cannabix Technologies (FRA:8CT) has a 3-Year RORE % of 25.00 as of Jan. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Cannabix Technologies and its competitors. According to the industry distribution chart, Cannabix Technologies ranks #167 out of 781 companies in the Medical Devices & Instruments industry, placing it in the top 21.4%.
Is Cannabix Technologies' 3-Year RORE % too high?
Cannabix Technologies' current 3-Year RORE % is 25.00. Based on the distribution chart, Cannabix Technologies ranks #167 out of 781 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Cannabix Technologies has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Cannabix Technologies' 3-Year RORE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cannabix Technologies ranks #167 out of 781 companies for 3-Year RORE %. This places Cannabix Technologies in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Cannabix Technologies and its competitors. Cannabix Technologies's current 3-Year RORE % is 25.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabix Technologies stock overvalued right now?
Cannabix Technologies (FRA:8CT) has a current 3-Year RORE % of 25.00. The current 3-Year RORE % is 25.00. Cannabix Technologies' overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Cannabix Technologies (FRA:8CT), the current 3-Year RORE % is 25.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabix Technologies Business Description

Address 3292 Production Way, Suite 501, Burnaby, BC, CAN, V5A 4R4
Cannabix Technologies Inc is engaged in the development of marijuana and alcohol breath testing technologies. Its products are Cannabix Marijuana Breath Test and BreathLogix Alcohol Breathalyzer.
32GF Score

Get the complete analysis for FRA:8CT

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.36
Price